255 related articles for article (PubMed ID: 33063666)
1. High-resolution structures of multiple 5-HT
Basak S; Kumar A; Ramsey S; Gibbs E; Kapoor A; Filizola M; Chakrapani S
Elife; 2020 Oct; 9():. PubMed ID: 33063666
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of setron-mediated inhibition of full-length 5-HT
Basak S; Gicheru Y; Kapoor A; Mayer ML; Filizola M; Chakrapani S
Nat Commun; 2019 Jul; 10(1):3225. PubMed ID: 31324772
[TBL] [Abstract][Full Text] [Related]
3. The Binding of Palonosetron and Other Antiemetic Drugs to the Serotonin 5-HT3 Receptor.
Zarkadas E; Zhang H; Cai W; Effantin G; Perot J; Neyton J; Chipot C; Schoehn G; Dehez F; Nury H
Structure; 2020 Oct; 28(10):1131-1140.e4. PubMed ID: 32726573
[TBL] [Abstract][Full Text] [Related]
4. Cryo-EM structure of 5-HT
Basak S; Gicheru Y; Samanta A; Molugu SK; Huang W; Fuente M; Hughes T; Taylor DJ; Nieman MT; Moiseenkova-Bell V; Chakrapani S
Nat Commun; 2018 Feb; 9(1):514. PubMed ID: 29410406
[TBL] [Abstract][Full Text] [Related]
5. Cryo-EM reveals two distinct serotonin-bound conformations of full-length 5-HT
Basak S; Gicheru Y; Rao S; Sansom MSP; Chakrapani S
Nature; 2018 Nov; 563(7730):270-274. PubMed ID: 30401837
[TBL] [Abstract][Full Text] [Related]
6. Mapping the molecular motions of 5-HT
Peverini L; Shi S; Medjebeur K; Corringer PJ
Elife; 2024 Jun; 12():. PubMed ID: 38913422
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for partial agonism in 5-HT
Felt K; Stauffer M; Salas-Estrada L; Guzzo PR; Xie D; Huang J; Filizola M; Chakrapani S
Nat Struct Mol Biol; 2024 Apr; 31(4):598-609. PubMed ID: 38177669
[TBL] [Abstract][Full Text] [Related]
8. In silico investigation into the interactions between murine 5-HT
Lohning AE; Marx W; Isenring L
J Mol Graph Model; 2016 Nov; 70():315-327. PubMed ID: 27816008
[TBL] [Abstract][Full Text] [Related]
9. Conformational transitions of the serotonin 5-HT
Polovinkin L; Hassaine G; Perot J; Neumann E; Jensen AA; Lefebvre SN; Corringer PJ; Neyton J; Chipot C; Dehez F; Schoehn G; Nury H
Nature; 2018 Nov; 563(7730):275-279. PubMed ID: 30401839
[TBL] [Abstract][Full Text] [Related]
10. Molecular Dynamics Refinement of Open State Serotonin 5-HT
Li Z; Chan KC; Nickels JD; Cheng X
J Chem Inf Model; 2023 Feb; 63(4):1196-1207. PubMed ID: 36757760
[TBL] [Abstract][Full Text] [Related]
11. A triad of residues is functionally transferrable between 5-HT
Mosesso R; Dougherty DA
J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
[TBL] [Abstract][Full Text] [Related]
12. A New Mechanism of Receptor Targeting by Interaction between Two Classes of Ligand-Gated Ion Channels.
Emerit MB; Baranowski C; Diaz J; Martinez A; Areias J; Alterio J; Masson J; Boué-Grabot E; Darmon M
J Neurosci; 2016 Feb; 36(5):1456-70. PubMed ID: 26843630
[TBL] [Abstract][Full Text] [Related]
13. Ondansetron and granisetron binding orientation in the 5-HT(3) receptor determined by unnatural amino acid mutagenesis.
Duffy NH; Lester HA; Dougherty DA
ACS Chem Biol; 2012 Oct; 7(10):1738-45. PubMed ID: 22873819
[TBL] [Abstract][Full Text] [Related]
14. Modeling and Mutational Analysis of the Binding Mode for the Multimodal Antidepressant Drug Vortioxetine to the Human 5-HT
Ladefoged LK; Munro L; Pedersen AJ; Lummis SCR; Bang-Andersen B; Balle T; Schiøtt B; Kristensen AS
Mol Pharmacol; 2018 Dec; 94(6):1421-1434. PubMed ID: 30257860
[TBL] [Abstract][Full Text] [Related]
15. Binding interactions of antagonists with 5-hydroxytryptamine3A receptor models.
Maksay G; Bikádi Z; Simonyi M
J Recept Signal Transduct Res; 2003; 23(2-3):255-70. PubMed ID: 14626451
[TBL] [Abstract][Full Text] [Related]
16. Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects.
Kast RE; Foley KF
Eur J Cancer Care (Engl); 2007 Jul; 16(4):351-4. PubMed ID: 17587360
[TBL] [Abstract][Full Text] [Related]
17. Nondepolarizing neuromuscular blockers inhibit the serotonin-type 3A receptor expressed in Xenopus oocytes.
Min KT; Wu CL; Yang J
Anesth Analg; 2000 Feb; 90(2):476-81. PubMed ID: 10648343
[TBL] [Abstract][Full Text] [Related]
18. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
Gregory RE; Ettinger DS
Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of antiemetic effect of various dosage regimens of azasetron hydrochloride based on 5-HT3 receptor occupancy of serotonin].
Yamada Y; Fujita M; Okuyama K; Takayanagi R; Ozeki T; Yokoyama H; Iga T
Yakugaku Zasshi; 2007 Feb; 127(2):353-7. PubMed ID: 17268155
[TBL] [Abstract][Full Text] [Related]
20. Conformational Changes in the 5-HT
Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
